Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 74 | 2024 | 8599 | 5.450 |
Why?
|
Amyloid beta-Peptides | 58 | 2024 | 3839 | 3.950 |
Why?
|
tau Proteins | 29 | 2024 | 2095 | 2.460 |
Why?
|
Memory Disorders | 14 | 2024 | 1198 | 1.780 |
Why?
|
Sex Characteristics | 14 | 2024 | 2639 | 1.670 |
Why?
|
Positron-Emission Tomography | 49 | 2024 | 6485 | 1.670 |
Why?
|
Apolipoprotein E4 | 12 | 2024 | 708 | 1.250 |
Why?
|
Cognition | 32 | 2024 | 6990 | 1.130 |
Why?
|
Tauopathies | 2 | 2020 | 320 | 1.000 |
Why?
|
Neuropsychological Tests | 24 | 2024 | 7045 | 0.910 |
Why?
|
Aging | 17 | 2024 | 8708 | 0.850 |
Why?
|
Brain | 40 | 2024 | 27112 | 0.840 |
Why?
|
Chromosomes, Human, X | 1 | 2024 | 321 | 0.820 |
Why?
|
Diagnostic Self Evaluation | 6 | 2020 | 224 | 0.740 |
Why?
|
Parietal Lobe | 2 | 2024 | 852 | 0.720 |
Why?
|
Apolipoproteins E | 6 | 2023 | 1444 | 0.690 |
Why?
|
Australia | 9 | 2022 | 1250 | 0.680 |
Why?
|
Disease Progression | 19 | 2023 | 13506 | 0.670 |
Why?
|
Cognition Disorders | 8 | 2023 | 3979 | 0.660 |
Why?
|
Frontal Lobe | 2 | 2024 | 1420 | 0.660 |
Why?
|
Aniline Compounds | 8 | 2024 | 1069 | 0.660 |
Why?
|
Carbolines | 5 | 2023 | 296 | 0.640 |
Why?
|
Dementia | 6 | 2023 | 2686 | 0.640 |
Why?
|
Heterozygote | 5 | 2023 | 2787 | 0.630 |
Why?
|
Aged | 84 | 2024 | 169289 | 0.610 |
Why?
|
Longitudinal Studies | 26 | 2024 | 14605 | 0.590 |
Why?
|
Aged, 80 and over | 48 | 2024 | 58976 | 0.580 |
Why?
|
Leukoaraiosis | 1 | 2018 | 116 | 0.570 |
Why?
|
Memory | 6 | 2023 | 2188 | 0.560 |
Why?
|
Cognitive Reserve | 4 | 2024 | 92 | 0.550 |
Why?
|
Thiazoles | 7 | 2024 | 1517 | 0.540 |
Why?
|
Amyloid | 9 | 2024 | 841 | 0.520 |
Why?
|
Estrogen Replacement Therapy | 1 | 2022 | 1208 | 0.510 |
Why?
|
Amyloidosis | 4 | 2023 | 817 | 0.470 |
Why?
|
Neurology | 1 | 2022 | 780 | 0.450 |
Why?
|
Male | 85 | 2024 | 360804 | 0.450 |
Why?
|
Female | 89 | 2024 | 392644 | 0.450 |
Why?
|
Humans | 122 | 2024 | 761504 | 0.440 |
Why?
|
Nerve Net | 4 | 2024 | 2290 | 0.430 |
Why?
|
Cross-Sectional Studies | 22 | 2024 | 26125 | 0.420 |
Why?
|
Magnetic Resonance Imaging | 20 | 2024 | 36426 | 0.400 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2017 | 710 | 0.390 |
Why?
|
Menopause | 4 | 2024 | 1646 | 0.380 |
Why?
|
Peptide Fragments | 4 | 2023 | 5112 | 0.370 |
Why?
|
Clinical Trials as Topic | 2 | 2017 | 8002 | 0.360 |
Why?
|
Temporal Lobe | 5 | 2024 | 1695 | 0.340 |
Why?
|
Life Style | 3 | 2023 | 3917 | 0.340 |
Why?
|
Ethylene Glycols | 3 | 2021 | 190 | 0.340 |
Why?
|
Neocortex | 4 | 2024 | 417 | 0.330 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1666 | 0.330 |
Why?
|
Self Report | 7 | 2024 | 3724 | 0.330 |
Why?
|
Middle Aged | 50 | 2024 | 220895 | 0.330 |
Why?
|
Depressive Disorder, Major | 3 | 2022 | 4761 | 0.320 |
Why?
|
Hormones | 2 | 2023 | 869 | 0.310 |
Why?
|
Entorhinal Cortex | 3 | 2019 | 287 | 0.310 |
Why?
|
Patient Selection | 1 | 2019 | 4244 | 0.270 |
Why?
|
Radiopharmaceuticals | 4 | 2020 | 2651 | 0.260 |
Why?
|
Affect | 3 | 2023 | 1486 | 0.260 |
Why?
|
Sex Factors | 5 | 2024 | 10552 | 0.240 |
Why?
|
Depression | 6 | 2024 | 8124 | 0.220 |
Why?
|
Hematologic Tests | 1 | 2024 | 239 | 0.210 |
Why?
|
Sleep Initiation and Maintenance Disorders | 2 | 2023 | 1081 | 0.210 |
Why?
|
Apolipoprotein E2 | 1 | 2023 | 135 | 0.210 |
Why?
|
Endophenotypes | 1 | 2024 | 255 | 0.210 |
Why?
|
Learning Curve | 1 | 2023 | 230 | 0.200 |
Why?
|
Atrophy | 6 | 2024 | 1633 | 0.190 |
Why?
|
Fornix, Brain | 1 | 2019 | 71 | 0.160 |
Why?
|
Resilience, Psychological | 2 | 2024 | 788 | 0.160 |
Why?
|
Occipital Lobe | 1 | 2020 | 374 | 0.160 |
Why?
|
Death Certificates | 1 | 2019 | 167 | 0.160 |
Why?
|
Case-Control Studies | 6 | 2019 | 22176 | 0.150 |
Why?
|
Phenanthrolines | 1 | 2017 | 50 | 0.150 |
Why?
|
Judgment | 1 | 2020 | 273 | 0.150 |
Why?
|
Behavior Therapy | 2 | 2021 | 879 | 0.150 |
Why?
|
Hyperlipidemias | 1 | 2022 | 771 | 0.140 |
Why?
|
Immunity | 1 | 2022 | 996 | 0.140 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2024 | 895 | 0.130 |
Why?
|
Social Behavior | 1 | 2023 | 1135 | 0.130 |
Why?
|
Plaque, Amyloid | 1 | 2020 | 760 | 0.130 |
Why?
|
Diet, Fat-Restricted | 1 | 2018 | 329 | 0.130 |
Why?
|
Forecasting | 2 | 2022 | 2928 | 0.130 |
Why?
|
Presenilin-1 | 1 | 2020 | 660 | 0.130 |
Why?
|
Risk Factors | 13 | 2024 | 74206 | 0.130 |
Why?
|
Databases, Bibliographic | 1 | 2015 | 130 | 0.120 |
Why?
|
Computers, Handheld | 1 | 2017 | 210 | 0.120 |
Why?
|
Hypercholesterolemia | 1 | 2022 | 1141 | 0.120 |
Why?
|
Online Systems | 1 | 2015 | 182 | 0.120 |
Why?
|
Risk Reduction Behavior | 1 | 2021 | 1112 | 0.110 |
Why?
|
Learning | 3 | 2023 | 1740 | 0.110 |
Why?
|
Cerebrovascular Circulation | 1 | 2024 | 2727 | 0.110 |
Why?
|
Microglia | 1 | 2022 | 1361 | 0.110 |
Why?
|
Principal Component Analysis | 1 | 2017 | 943 | 0.110 |
Why?
|
Activities of Daily Living | 3 | 2020 | 2421 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2024 | 3492 | 0.110 |
Why?
|
Risk | 3 | 2020 | 9610 | 0.100 |
Why?
|
Fractures, Malunited | 1 | 2013 | 82 | 0.100 |
Why?
|
Hippocampus | 2 | 2019 | 3766 | 0.100 |
Why?
|
Cerebral Hemorrhage | 1 | 2024 | 2656 | 0.100 |
Why?
|
Executive Function | 3 | 2017 | 1389 | 0.100 |
Why?
|
Awareness | 1 | 2016 | 648 | 0.100 |
Why?
|
Cardiovascular Diseases | 4 | 2023 | 15500 | 0.100 |
Why?
|
Socioeconomic Factors | 4 | 2022 | 7827 | 0.100 |
Why?
|
Cause of Death | 2 | 2021 | 3683 | 0.100 |
Why?
|
Genome-Wide Association Study | 4 | 2024 | 12690 | 0.100 |
Why?
|
Follow-Up Studies | 7 | 2020 | 39106 | 0.100 |
Why?
|
Corpus Striatum | 1 | 2018 | 1235 | 0.100 |
Why?
|
Psychomotor Performance | 2 | 2023 | 1881 | 0.100 |
Why?
|
Cohort Studies | 8 | 2024 | 41487 | 0.100 |
Why?
|
Interview, Psychological | 1 | 2015 | 809 | 0.100 |
Why?
|
Diet, Mediterranean | 1 | 2018 | 740 | 0.100 |
Why?
|
Amyloidogenic Proteins | 2 | 2023 | 151 | 0.100 |
Why?
|
Cerebrovascular Disorders | 1 | 2018 | 1474 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 5 | 2022 | 17904 | 0.090 |
Why?
|
Alleles | 2 | 2020 | 6863 | 0.090 |
Why?
|
Severity of Illness Index | 4 | 2018 | 15842 | 0.090 |
Why?
|
Radionuclide Imaging | 1 | 2015 | 1972 | 0.090 |
Why?
|
Brain Chemistry | 1 | 2014 | 960 | 0.090 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2018 | 9000 | 0.090 |
Why?
|
Bone Plates | 1 | 2013 | 466 | 0.090 |
Why?
|
Attitude | 1 | 2015 | 775 | 0.090 |
Why?
|
Bone Screws | 1 | 2013 | 532 | 0.080 |
Why?
|
Contrast Media | 2 | 2019 | 5311 | 0.080 |
Why?
|
Prospective Studies | 8 | 2023 | 54425 | 0.080 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2015 | 6019 | 0.080 |
Why?
|
Interviews as Topic | 1 | 2015 | 2696 | 0.070 |
Why?
|
Logistic Models | 3 | 2017 | 13255 | 0.070 |
Why?
|
Multiple Sclerosis | 1 | 2022 | 3220 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2018 | 3575 | 0.070 |
Why?
|
Fracture Fixation, Internal | 1 | 2013 | 973 | 0.070 |
Why?
|
Adult | 9 | 2023 | 221177 | 0.070 |
Why?
|
Psychotropic Drugs | 1 | 1992 | 888 | 0.070 |
Why?
|
Independent Living | 2 | 2021 | 579 | 0.060 |
Why?
|
Geriatric Assessment | 1 | 2013 | 1410 | 0.060 |
Why?
|
Pilot Projects | 2 | 2017 | 8631 | 0.060 |
Why?
|
Age Factors | 2 | 2019 | 18395 | 0.060 |
Why?
|
Hip Fractures | 1 | 2013 | 988 | 0.060 |
Why?
|
Prognosis | 2 | 2017 | 29625 | 0.060 |
Why?
|
Adaptation, Psychological | 1 | 2015 | 2629 | 0.060 |
Why?
|
Cerebral Cortex | 1 | 2020 | 5777 | 0.060 |
Why?
|
Linear Models | 3 | 2019 | 5871 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5840 | 0.050 |
Why?
|
Telemedicine | 1 | 2021 | 3051 | 0.050 |
Why?
|
Reoperation | 1 | 2013 | 4303 | 0.050 |
Why?
|
Apolipoprotein E3 | 1 | 2023 | 107 | 0.050 |
Why?
|
Radiation Injuries | 1 | 2010 | 1189 | 0.050 |
Why?
|
Body Mass Index | 1 | 2020 | 12953 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14666 | 0.050 |
Why?
|
Educational Status | 2 | 2020 | 2522 | 0.050 |
Why?
|
Biomedical Research | 1 | 2016 | 3429 | 0.050 |
Why?
|
Patient Care Team | 1 | 1992 | 2521 | 0.040 |
Why?
|
Common Variable Immunodeficiency | 1 | 2001 | 101 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12059 | 0.040 |
Why?
|
Locus Coeruleus | 1 | 2022 | 230 | 0.040 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2020 | 247 | 0.040 |
Why?
|
Length of Stay | 1 | 2013 | 6425 | 0.040 |
Why?
|
Loneliness | 1 | 2022 | 203 | 0.040 |
Why?
|
Colombia | 1 | 2020 | 282 | 0.040 |
Why?
|
Canada | 1 | 2024 | 2122 | 0.040 |
Why?
|
Spouses | 1 | 2021 | 283 | 0.040 |
Why?
|
Personality | 1 | 2022 | 554 | 0.040 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2010 | 2790 | 0.040 |
Why?
|
X Chromosome | 1 | 2001 | 816 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2001 | 732 | 0.040 |
Why?
|
Neurofibrillary Tangles | 1 | 2020 | 457 | 0.040 |
Why?
|
Lymphoproliferative Disorders | 1 | 2001 | 531 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2024 | 15936 | 0.040 |
Why?
|
Boston | 2 | 2023 | 9326 | 0.040 |
Why?
|
Qualitative Research | 2 | 2019 | 3023 | 0.040 |
Why?
|
Estrogens | 1 | 2024 | 1522 | 0.040 |
Why?
|
Genotype | 2 | 2023 | 12990 | 0.040 |
Why?
|
Brain Stem | 1 | 2022 | 858 | 0.030 |
Why?
|
Memory, Short-Term | 1 | 2023 | 982 | 0.030 |
Why?
|
Homozygote | 1 | 2021 | 1776 | 0.030 |
Why?
|
Brain Mapping | 1 | 2011 | 6630 | 0.030 |
Why?
|
Iron | 1 | 2024 | 1793 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 588 | 0.030 |
Why?
|
Germany | 1 | 2017 | 875 | 0.030 |
Why?
|
Patient Compliance | 2 | 2018 | 2690 | 0.030 |
Why?
|
Substance-Related Disorders | 1 | 1992 | 4420 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2330 | 0.030 |
Why?
|
Benzothiazoles | 1 | 2016 | 247 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2018 | 1572 | 0.030 |
Why?
|
Glioblastoma | 1 | 2010 | 3482 | 0.030 |
Why?
|
Anthropometry | 1 | 2018 | 1349 | 0.030 |
Why?
|
Psychometrics | 1 | 2023 | 3065 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3305 | 0.030 |
Why?
|
Complementary Therapies | 1 | 2017 | 486 | 0.030 |
Why?
|
Self Concept | 1 | 2018 | 1045 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2023 | 5247 | 0.030 |
Why?
|
Attention | 1 | 2023 | 2396 | 0.030 |
Why?
|
Models, Neurological | 1 | 2020 | 1767 | 0.020 |
Why?
|
Mental Disorders | 1 | 1992 | 6845 | 0.020 |
Why?
|
Commitment of Mentally Ill | 1 | 1992 | 94 | 0.020 |
Why?
|
Overweight | 1 | 2023 | 2417 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2010 | 9280 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2001 | 2872 | 0.020 |
Why?
|
Antisocial Personality Disorder | 1 | 1992 | 224 | 0.020 |
Why?
|
Weight-Bearing | 1 | 2013 | 532 | 0.020 |
Why?
|
Neurodegenerative Diseases | 1 | 2020 | 1087 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2015 | 1702 | 0.020 |
Why?
|
Parents | 1 | 2024 | 3563 | 0.020 |
Why?
|
Fracture Healing | 1 | 2013 | 445 | 0.020 |
Why?
|
Animals | 4 | 2024 | 168459 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 13367 | 0.020 |
Why?
|
Internet | 1 | 2021 | 3092 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2010 | 9031 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2019 | 2400 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2018 | 3769 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2001 | 4936 | 0.020 |
Why?
|
Oligodendroglioma | 1 | 2010 | 279 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2023 | 4481 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20570 | 0.020 |
Why?
|
Weight Loss | 1 | 2018 | 2684 | 0.020 |
Why?
|
Brain Concussion | 1 | 2018 | 1404 | 0.020 |
Why?
|
Range of Motion, Articular | 1 | 2013 | 1588 | 0.020 |
Why?
|
Anxiety | 1 | 2021 | 4573 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12725 | 0.020 |
Why?
|
Managed Care Programs | 1 | 1992 | 940 | 0.020 |
Why?
|
Mental Health | 1 | 2021 | 3250 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2015 | 6228 | 0.020 |
Why?
|
Registries | 1 | 2022 | 8224 | 0.020 |
Why?
|
Sleep | 1 | 2021 | 4768 | 0.020 |
Why?
|
Violence | 1 | 1992 | 936 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20098 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3357 | 0.020 |
Why?
|
Astrocytoma | 1 | 2010 | 775 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18252 | 0.020 |
Why?
|
Continuity of Patient Care | 1 | 1992 | 1069 | 0.010 |
Why?
|
Prevalence | 1 | 2021 | 15732 | 0.010 |
Why?
|
Recovery of Function | 1 | 2013 | 2979 | 0.010 |
Why?
|
Liver | 1 | 2018 | 7529 | 0.010 |
Why?
|
Mice | 2 | 2024 | 81525 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15266 | 0.010 |
Why?
|
Infectious Mononucleosis | 1 | 2001 | 133 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2020 | 80636 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2010 | 12974 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12947 | 0.010 |
Why?
|
Incidence | 1 | 2018 | 21353 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2013 | 5492 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2018 | 64680 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 2001 | 978 | 0.010 |
Why?
|
Genes | 1 | 2001 | 1823 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23995 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2001 | 2748 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2001 | 2180 | 0.010 |
Why?
|
Chronic Disease | 1 | 1992 | 9318 | 0.010 |
Why?
|
United States | 1 | 2024 | 72334 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 4575 | 0.010 |
Why?
|
Pedigree | 1 | 2001 | 4542 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 59243 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2001 | 4111 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2011 | 22169 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2001 | 13446 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2001 | 17635 | 0.000 |
Why?
|
Child, Preschool | 1 | 2001 | 42230 | 0.000 |
Why?
|
Child | 1 | 2001 | 80153 | 0.000 |
Why?
|
Concepts
(256)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(59)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_